Bayer has collaborated with healthcare professionals to develop a series of patient case studies. These case studies were developed as a promotional educational resource and share the real-world experience of expert healthcare professionals in the management of their patients with high-risk non-metastatic castration resistant prostate cancer (nmCRPC) across the whole patient journey, from initial diagnosis and treatment decisions to their management today.
These case studies share a range of different patient profiles including different ages, treatment histories, concomitant medications and outcomes to help visualise and identify patients with high-risk nmCRPC who may be suitable for treatment with NUBEQA.
By Ms Debbie Victor, Winner of BAUN 2021 Nurse of the Year, Uro-oncology Cancer Nurse Specialist, Royal Cornwall Hospitals NHS Trust
Patient: 60 years with some comorbidities and concomitant meds. Hobbies include going to the gym.
Treatment goal: Provide emotional support for PSA anxiety
Uro-Oncology Clinical Nurse Specialist, Royal Cornwall Hospital.
Debbie Victor has received advisory and speaker fees from Astellas, Pfizer, Bayer and Ipsen.
Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Bayer plc Tel: 01182 063 500, Fax: 01182 063 703, Email: pvuk@bayer.com.
If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.